المؤلفون: Huppert, Laura A, Daud, Adil I

المصدر: Human Vaccines & Immunotherapeutics. 18(3)

مصطلحات موضوعية: Cancer, Immunization, Biotechnology, Vaccine Related, Development of treatments and therapeutic interventions, 5.1 Pharmaceuticals, Cancer Vaccines, Humans, Immunotherapy, Injections, Intralesional, Melanoma, Tumor Microenvironment, Vaccination, Intratumoral, intralesional, melanoma, in situ vaccination, Immunology, Medical Microbiology, Pharmacology and Pharmaceutical Sciences, Virology

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/6t5275tpTest

المؤلفون: Tsai, Katy K, Zarzoso, Inés, Daud, Adil I

المصدر: Human Vaccines & Immunotherapeutics. 10(11)

مصطلحات موضوعية: Cancer, Immunization, Climate-Related Exposures and Conditions, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, B7-H1 Antigen, CTLA-4 Antigen, Humans, Immunotherapy, Lymphocyte Activation, Melanoma, Nivolumab, Programmed Cell Death 1 Receptor, T-Lymphocytes, BMS-936559, PD-1, PD-L1, PD-L2, immunotherapy, MPDL3280A, melanoma, nivolumab, pembrolizumab, AE, adverse event, APC, antigen presenting cell, ASCO, American Society of Clinical Oncology, CTLA-4, cytotoxic T-lymphocyte-associated protein 4, FDA, Food and Drug Administration, gp100, glycoprotein 100 vaccine, Ig, immunoglobulin, ITIM, immunoreceptor tyrosine-based inhibitory motif, ITSM, immunoreceptor tyrosine-based switch motif, MAPK, mitogen-activated protein kinase, MHC, major histocompatibility complex, NK, natural killer, ORR, objective response rate, OS, overall survival, PD, progressive disease, programmed cell death 1, programmed cell death ligand 1, PFS, progression free survival, TCR, T cell receptor, TIL, tumor infiltrating lymphocyte, AE, adverse event, APC, antigen presenting cell, ASCO, American Society of Clinical Oncology, CTLA-4, cytotoxic T-lymphocyte-associated protein 4, FDA, Food and Drug Administration, ITIM, immunoreceptor tyrosine-based inhibitory motif, ITSM, immunoreceptor tyrosine-based switch motif, Ig, immunoglobulin, MAPK, mitogen-activated protein kinase, MHC, major histocompatibility complex, NK, natural killer, ORR, objective response rate, OS, overall survival, PD, progressive disease, PD-1, programmed cell death 1, PD-L1, programmed cell death ligand 1, PFS, progression free survival, TCR, T cell receptor, TIL, tumor infiltrating lymphocyte, gp100, glycoprotein 100 vaccine, Immunology, Medical Microbiology, Pharmacology and Pharmaceutical Sciences, Virology

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/49q8w2djTest